Clinical Trials Directory

Trials / Unknown

UnknownNCT05432063

Urdu Version of Oxford Shoulder Score Scale: Reliability and Validity Study

Evaluation of Reliability and Validity of Urdu Version of Oxford Shoulder Score Scale Among Pakistani Population

Status
Unknown
Phase
Study type
Observational
Enrollment
105 (estimated)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary goal of this study is to translate and culturally adapt the Oxford Shoulder Score Scale into Urdu, as well as to assess its reliability and validity in the Urdu-speaking Pakistani community. This research will also look at the relationship between Oxford Shoulder Score Scale and the Shoulder Pain And Disability Index and Short Form - 36 scores for shoulder pain.

Detailed description

The English version of the Oxford Shoulder Score Scale will be translated and culturally modified into Urdu. The Oxford Shoulder Score Scale, as well as other correlation measures, will be disseminated among 104 individuals in the Pakistani Urdu speaking community, who will be chosen using a convenience sample approach and based on pre-defined inclusion and exclusion criteria. For the intra- and inter-observer validity and reliability of the Oxford Shoulder Score Scale, Shoulder Pain And Disability Index, and Short Form - 36, questionnaires will be filled on the same day by two observers, with a two-hour gap between the first and second application. This is the inter-observer evaluation. The third application for the intra-observer evaluation will be completed after 7 days. Statistical Package of Social Sciences Version 26 will be used to enter and analyses the data. The internal consistency will be assessed using the Cronbach alpha value. The test-retest reliability will be assessed using an inter-class correlation coefficient. The content validity, criteria and construct validity, as well as responsiveness, of the Oxford Shoulder Score Scale scale will be assessed.

Conditions

Timeline

Start date
2021-05-30
Primary completion
2022-07-01
Completion
2022-07-01
First posted
2022-06-27
Last updated
2022-06-27

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05432063. Inclusion in this directory is not an endorsement.